PubMed · 8921997
The source did not provide an abstract. Follow the original record for more information.
Explore connections, maps & timelines
M Wagner. 1996. [Endomethasone without formaldehyde].. https://pubmed.ncbi.nlm.nih.gov/8921997/
Cite the original work for its findings. Save a collection to share your selection of sources.
KEEP EXPLORING
Several O/W microemulsions, O/W and W/O emulsions and a W/O/W multiple emulsion were prepared using non-ionic, non-ethoxylated, skin compatible emulsifiers. Ascorbic acid (vitamin C) was added to the emulsified systems and its stability against oxidation was studied at 45.0 degrees C in aerobic conditions and compared with that in aqueous solutions at different pH values. All emulsified systems provided protection to ascorbic acid, as its degradation rate, which increased with increasing pH, was slower in emulsified systems than in aqueous solutions. The highest protection of ascorbic acid was when it was dissolved in the inner aqueous phase of the W/O/W multiple emulsion, both at 45 and at 20 degrees C for long storage. A pseudo first-order mechanism was hypothesised for ascorbic acid degradation in the experimental conditions for as long as abundant dissolved oxygen was present.
Dermal exposure to jet fuels has received increased attention with the recent release of newer fuels with novel performance additives. The purpose of these studies was to assess the percutaneous absorption and cutaneous disposition of topically applied (25 microl/5 cm(2)) neat Jet-A, JP-8, and JP-8(100) jet fuels by monitoring the absorptive flux of the marker components 14C naphthalene and (3)H dodecane simultaneously applied nonoccluded to isolated perfused porcine skin flaps (IPPSF) (n = 4). Absorption of 14C hexadecane was estimated from JP-8 fuel. Absorption and disposition of naphthalene and dodecane were also monitored using a nonvolatile JP-8 fraction reflecting exposure to residual fuel that might occur 24 h after a jet fuel spill. In all studies, perfusate, stratum corneum, and skin concentrations were measured over 5 h. Naphthalene absorption had a clear peak absorptive flux at less than 1 h, while dodecane and hexadecane had prolonged, albeit significantly lower, absorption flux profiles. Within JP-8, the rank order of absorption for all marker components was (mean +/- SEM % dose) naphthalene (1.17 +/- 0.07) > dodecane (0.63 +/- 0.04) > hexadecane (0.18 +/- 0.08). In contrast, deposition within dosed skin showed the reverse pattern. Naphthalene absorption into perfusate was similar across all fuel types, however total penetration into and through skin was highest with JP-8(100). Dodecane absorption and total penetration was greatest from JP-8. Absorption of both markers from aged JP-8 was lower than other fuels, yet the ratio of skin deposition to absorption was greatest for this treatment group. In most exposure scenarios, absorption into perfusate did not directly correlate to residual skin concentrations. These studies demonstrated different absorption profiles for the three marker compounds, differential effects of jet fuel types on naphthalene and dodecane absorption, and uncoupling of perfusate absorption from skin disposition.
A multi-centered field trial was carried out in the Netherlands to evaluate the efficacy of a ready-to-use 5% dicyclanil formulation as a preventative of natural flystrike on lambs. In four different sites a total of 1215 lambs treated with dicyclanil were compared with 431 untreated lambs during periods of 15 to 16 weeks. Efficacy was assessed by calculating the weekly cumulative strike rate for each site and treatment group and the percentage reduction achieved by dicyclanil. In two of the four sites untreated controls did not receive enough fly challenge and were not considered for efficacy assessment. At the other two sites untreated controls reached cumulative strike rates of 10.5 and 19.5% 15 and 16 weeks after treatment, respectively. None of the 549 lambs treated with dicyclanil at these two sites were struck, resulting in a 100% reduction of flystrike during the whole length of the trial.